Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Gilead Sciences Announced Phase 3 Purpose 1 Trial Data, Showing Zero Infections And 100% Efficacy And Superiority Of Lenacapavir To Background HIV Incidence For The Investigational Use Of HIV Prevention In Cisgender Women

Author: Benzinga Newsdesk | July 24, 2024 04:33am

Posted In: GILD